Immunosuppression and immunomodulation.
Goust
J M
JM
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston.
Stevenson
H
H
Galbraith
R
R
Virella
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects; D013951:Thymus Hormones / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000477:Alkylating Agents; D000963:Antimetabolites; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D013951:Thymus Hormones